| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |